Clinical Trial Update: Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on Lucentis (ranibizumab) assessing efficacy and safety in diabetic macular edema and related macular conditions with a spaced-o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema
• Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Macular Edema, Macular Degeneration | Phase 3 | Status: TERMINATED | Results posted: 2020-10-22